Literature DB >> 33488630

SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response.

Jackson S Turner1, Aaron Day2, Wafaa B Alsoussi1, Zhuoming Liu3, Jane A O'Halloran4, Rachel M Presti4, Bruce K Patterson5, Sean P J Whelan3, Ali H Ellebedy1, Philip A Mudd2.   

Abstract

Prolonged shedding of viral RNA occurs in some individuals following SARS-CoV-2 infection. We perform comprehensive immunologic evaluation of one individual with prolonged shedding. The case subject recovered from severe COVID-19 and tested positive for SARS-CoV-2 viral RNA repeatedly as many as 87 days after the first positive test, 97 days after symptom onset. The subject did not have any associated rise in anti-Spike protein antibody titers or plasma neutralization activity, arguing against re-infection. This index subject exhibited a profoundly diminished circulating CD8+ T cell population and correspondingly low SARS-CoV-2-specific CD8+ T cell responses when compared with a cohort of other recovering COVID-19 subjects. CD4+ T cell responses and neutralizing antibody responses developed as expected in this individual. Our results demonstrate that detectable viral RNA shedding in the upper airway can occur more than 3 months following infection in some individuals with COVID-19 and suggest that impaired CD8+ T cells may play a role in prolonged viral RNA shedding.
Copyright © 2021 Turner, Day, Alsoussi, Liu, O’Halloran, Presti, Patterson, Whelan, Ellebedy and Mudd.

Entities:  

Keywords:  CD4+ T cell; CD8+ T cell; COVID-19; SARS-CoV-2; cellular immunity

Mesh:

Substances:

Year:  2021        PMID: 33488630      PMCID: PMC7820941          DOI: 10.3389/fimmu.2020.618402

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  15 in total

1.  Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.

Authors:  Jackson S Turner; Tingting Lei; Aaron J Schmitz; Aaron Day; José Alberto Choreño-Parra; Luis Jiménez-Alvarez; Alfredo Cruz-Lagunas; Stacey L House; Joaquín Zúñiga; Ali H Ellebedy; Philip A Mudd
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

Review 2.  Virus-specific T cells as correlate of (cross-)protective immunity against influenza.

Authors:  Arwen F Altenburg; Guus F Rimmelzwaan; Rory D de Vries
Journal:  Vaccine       Date:  2014-12-09       Impact factor: 3.641

3.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

4.  Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.

Authors:  Daniela Weiskopf; Katharina S Schmitz; Alessandro Sette; Rory D de Vries; Matthijs P Raadsen; Alba Grifoni; Nisreen M A Okba; Henrik Endeman; Johannes P C van den Akker; Richard Molenkamp; Marion P G Koopmans; Eric C M van Gorp; Bart L Haagmans; Rik L de Swart
Journal:  Sci Immunol       Date:  2020-06-26

5.  Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.

Authors:  Ding Shi; Wenrui Wu; Qing Wang; Kaijin Xu; Jiaojiao Xie; Jingjing Wu; Longxian Lv; Jifang Sheng; Jing Guo; Kaicen Wang; Daiqiong Fang; Yating Li; Lanjuan Li
Journal:  J Infect Dis       Date:  2020-08-17       Impact factor: 5.226

6.  Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.

Authors:  Kun Wang; Xin Zhang; Jiaxing Sun; Jia Ye; Feilong Wang; Jing Hua; Huayu Zhang; Ting Shi; Qiang Li; Xiaodong Wu
Journal:  Chest       Date:  2020-06-20       Impact factor: 9.410

7.  Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.

Authors:  Philip A Mudd; Jeremy Chase Crawford; Jackson S Turner; Aisha Souquette; Daniel Reynolds; Diane Bender; James P Bosanquet; Nitin J Anand; David A Striker; R Scott Martin; Adrianus C M Boon; Stacey L House; Kenneth E Remy; Richard S Hotchkiss; Rachel M Presti; Jane A O'Halloran; William G Powderly; Paul G Thomas; Ali H Ellebedy
Journal:  Sci Adv       Date:  2020-12-09       Impact factor: 14.136

8.  CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14.

Authors:  Bruce K Patterson; Harish Seethamraju; Kush Dhody; Michael J Corley; Kazem Kazempour; Jay Lalezari; Alina P S Pang; Christopher Sugai; Eisa Mahyari; Edgar B Francisco; Amruta Pise; Hallison Rodrigues; Helen L Wu; Gabriela M Webb; Byung S Park; Scott Kelly; Nader Pourhassan; Alina Lelic; Lama Kdouh; Monica Herrera; Eric Hall; Benjamin N Bimber; Matthew Plassmeyer; Raavi Gupta; Oral Alpan; Jane A O'Halloran; Philip A Mudd; Enver Akalin; Lishomwa C Ndhlovu; Jonah B Sacha
Journal:  Int J Infect Dis       Date:  2020-11-10       Impact factor: 3.623

9.  Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.

Authors:  James Brett Case; Paul W Rothlauf; Rita E Chen; Zhuoming Liu; Haiyan Zhao; Arthur S Kim; Louis-Marie Bloyet; Qiru Zeng; Stephen Tahan; Lindsay Droit; Ma Xenia G Ilagan; Michael A Tartell; Gaya Amarasinghe; Jeffrey P Henderson; Shane Miersch; Mart Ustav; Sachdev Sidhu; Herbert W Virgin; David Wang; Siyuan Ding; Davide Corti; Elitza S Theel; Daved H Fremont; Michael S Diamond; Sean P J Whelan
Journal:  Cell Host Microbe       Date:  2020-07-03       Impact factor: 21.023

10.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

Authors:  Alba Grifoni; Daniela Weiskopf; Sydney I Ramirez; Jose Mateus; Jennifer M Dan; Carolyn Rydyznski Moderbacher; Stephen A Rawlings; Aaron Sutherland; Lakshmanane Premkumar; Ramesh S Jadi; Daniel Marrama; Aravinda M de Silva; April Frazier; Aaron F Carlin; Jason A Greenbaum; Bjoern Peters; Florian Krammer; Davey M Smith; Shane Crotty; Alessandro Sette
Journal:  Cell       Date:  2020-05-20       Impact factor: 66.850

View more
  5 in total

Review 1.  Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection.

Authors:  Krista L Newell; Adam T Waickman
Journal:  Curr Opin Immunol       Date:  2022-05-24       Impact factor: 7.268

Review 2.  Correlates of protection against SARS-CoV-2 infection and COVID-19 disease.

Authors:  David Goldblatt; Galit Alter; Shane Crotty; Stanley A Plotkin
Journal:  Immunol Rev       Date:  2022-06-05       Impact factor: 10.983

Review 3.  SARS-CoV-2 Infection and Pancreatic β Cell Failure.

Authors:  Keiichiro Mine; Seiho Nagafuchi; Hitoe Mori; Hirokazu Takahashi; Keizo Anzai
Journal:  Biology (Basel)       Date:  2021-12-24

4.  Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assays.

Authors:  Ketki Deshpande; Ullas Pt; Ojas Kaduskar; Neetu Vijay; Aparna Rakhe; Shankar Vidhate; Kirtee Khutwad; Gururaj Rao Deshpande; Bipin Tilekar; Sanskruti Saka; Kshitija Gadekar; Roshni Patil; Pragya Yadav; Varsha Potdar; Yogesh Gurav; Priyanka Gupta; Harmanmeet Kaur; Jitendra Narayan; Gajanan Sapkal; Priya Abraham
Journal:  J Med Virol       Date:  2021-08-10       Impact factor: 20.693

5.  Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses.

Authors:  Jacob K Files; Sanghita Sarkar; Tim R Fram; Sushma Boppana; Sarah Sterrett; Kai Qin; Anju Bansal; Dustin M Long; Steffanie Sabbaj; James J Kobie; Paul A Goepfert; Nathan Erdmann
Journal:  JCI Insight       Date:  2021-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.